Every one of those 1 sits in a single category, health-it. Galactovid is most often covered alongside Corexa Health, which appears in 1 of these 1 story. At 5, the average consequence score sits below the same-window beat average of 5.2.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Galactovid
Every one of those 1 sits in a single category, health-it. Galactovid is most often covered alongside Corexa Health, which appears in 1 of these 1 story. At 5, the average consequence score sits below the same-window beat average of 5.2. They are less corroborated than the beat average, carrying 2 original sources each against 2.2 for the same window. We currently track 1 Healthcare story that mention Galactovid, all published on August 12, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 40 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Galactovid. Shared-story counts are live from our verified record — not editorial picks.
Health IT firm DataMeds AI uses its EinsteinRx AI and PharmacyChain blockchain platforms to power a direct-to-consumer pharmacy launch of Long COVID supplements, with a market projected to reach $32.8B. A pending acquisition of the product maker adds vertical integration.